Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New procedure targets nerves to ease stubborn back pain

NCT ID NCT07559890

Symptom relief Sponsor: EPC Education s.r.o. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This study tests a procedure that uses heat to disable tiny nerves in the spine thought to cause chronic low back pain. It involves 100 adults who have had back pain for at least 6 months and show specific changes on MRI. The goal is to see if this treatment safely reduces pain and improves daily function.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

May 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Axial low back pain (with or without lateral component). * Presence of Modic type I or II changes at ≥ 1 level. * Age over 18 years. * Duration of pain ≥ 6 months. * Completion of full conservative management for ≥ 3 months. * Medial Branch Block (MBB) test performed with negative results/ or Facet Denervation done with unsatisfactory outcome (less than 50% improvement) after positive MBB test. Exclusion Criteria: * Coagulation disorders. * Platelet abnormalities. * Lack of informed consent. * Generalized solid tumor. * Hematopoietic malignancy. * Radicular pain. * Alternative primary pain generators other than axial low back pain. * Previous spinal surgery. * Targeted level located above L3/L4 * Osteoporosis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Basivertebral nerve ablation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Basivertebral nerve ablation Chronic back pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites in 3 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • EuroPainClinics Praha a.s

    RECRUITING

    Prague, 17000, Czechia

  • Europainclinics Sweden

    NOT_YET_RECRUITING

    Umeå, 90137, Sweden

  • Poliklinika Terasa

    NOT_YET_RECRUITING

    Košice, 04001, Slovakia

More trials for these conditions

Other studies related to the condition(s) this trial covers.